Clearside Biomedical Inc. priced low but increased the shares in its IPO to take off about where it expected. The company offered 7.2 million common shares priced at $7 apiece to raise $50.4 million and granted underwriters a 30-day option to purchase up to 1.08 million additional shares to fill overallotments, potentially adding $7.56 million to the raise.